Articles related to BRAIN TUMORS

The findings provide significant conceptual advances into cancer neuroscience and establish therapeutic avenues that are distinct from present amyloid-lowering strategies, aiming at degrading the existing amyloid plaques.

Among 8,391 women requiring meningioma surgery, prolonged desogestrel use showed location-specific risk patterns consistent with hormone-induced tumors, primarily affecting skull base regions.

Long-term follow-up data demonstrate a significant overall survival advantage with combination therapy, showing a hazard ratio of 0.54 (95% CI 0.31-0.95) for radiation plus temozolomide versus radiation alone in grade II gliomas.

A national case-control study of 108,366 women found that prolonged use of injectable medroxyprogesterone acetate was associated with a 5.55-fold increased risk of intracranial meningioma requiring surgery (95% CI 2.27-13.56), while levonorgestrel IUDs showed no increased risk.

The newly developed Real-CSF test offers a significant leap in diagnosing brain tumors, accurately identifying cancerous lesions in 67% of cases by analyzing cerebrospinal fluid for abnormal genetic material.

A recent study on glioma brain tumors reveals the significant role of epigenetic changes in tumor formation. This discovery offers promising avenues for targeted therapies, potentially transforming the approach to treating this devastating disease.